GlassScriptPhysician profile
Daniel K Coleman
NPI 1326335639
$1,371.34
in general payments reported to CMS, 2019-2025
9 companies · $71.76 in 2025
The $71.76 reported for 2025 was less than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $267 · 2020: $335 · 2021: $165 · 2022: $41.22 · 2023: $196 · 2024: $296 · 2025: $71.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $346 · Entertainment: $218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $345.70 |
| Entertainment | $218.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salvin Dental Specialties, INC. | $455.37 | 2020-2021 | |
| Keystone Dental INC. | $325.70 | 2019-2025 | |
| Dentsply Sirona INC | $230.93 | 2022-2024 | Tph Spectra Universal Composite Restorative Low Viscosity, Cerec |
| Zimmer Biomet Holdings, INC. | $132.18 | 2019 | |
| Align Technology, INC. | $123.04 | 2024 | Invisalign |
| Biohorizons Implant Systems INC. | $41.71 | 2021-2025 | Biohorizons Dental Implants |
| Kavo Dental Technologies LLC | $35.98 | 2019 | |
| Geistlich Pharma, North America, INC. | $13.77 | 2019 | |
| Straumann USA LLC | $12.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Coleman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.